MALAT1 and metabolic syndrome: In subjects with T2D, MetS and low HDL levels, a reduced expression of metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) was described in serum and in circulating exosomes, together with overexpression of H19 in patients with poor glycaemic control compared to subjects with glycated hemoglobin <7%.